3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024 ...
PepsiCo price target lowered to $160 from $183 at TD Cowen
TD Cowen analyst Robert Moskow lowered the firm’s price target on PepsiCo (PEP) to $160 from $183 and keeps a Hold rating on the shares. The ...
PepsiCo (PEP) Stock Moves -0.59%: What You Should Know
The latest trading day saw PepsiCo (PEP) settling at $145.40, representing a -0.59% change from its previous close.
PepsiCo Inc. stock underperforms Tuesday when compared to competitors
Shares of PepsiCo Inc. PEP slumped 0.59% to $145.40 Tuesday, on what proved to be an all-around dismal trading session for ...
Celsius Could Deliver Big Gains, But Faces Uncertainty
Celsius Holdings experienced significant growth, with revenue exceeding $1.3B and net income $200 million. Click here to find ...
Nvidia Stock Closed Tuesday Down 6% After Hitting All-Time Highs: What Happened?
Nvidia Corporation (NASDAQ: NVDA) shares traded lower on Tuesday following product announcements made during CES 2025. Broader weakness across markets following economic data Tuesday morning also ...
Why PepsiCo Is An Opportunity For Investors With A Long-Term Time Horizon
The uncertainties surrounding PepsiCo Inc's performance in 2025 are already reflected in its stock price, according to Piper ...
MBX Biosciences, Inc.: MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia
Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...
Piper initiates on soda stocks; Pepsi, Coca-Cola ‘overweight,’ Dr Pepper ‘neutral'
Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).